1. Home
  2. INVE vs ENTX Comparison

INVE vs ENTX Comparison

Compare INVE & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • ENTX
  • Stock Information
  • Founded
  • INVE 1990
  • ENTX 2010
  • Country
  • INVE United States
  • ENTX Israel
  • Employees
  • INVE N/A
  • ENTX N/A
  • Industry
  • INVE Computer peripheral equipment
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INVE Technology
  • ENTX Health Care
  • Exchange
  • INVE Nasdaq
  • ENTX Nasdaq
  • Market Cap
  • INVE 86.5M
  • ENTX 90.2M
  • IPO Year
  • INVE 1997
  • ENTX 2018
  • Fundamental
  • Price
  • INVE $3.51
  • ENTX $2.43
  • Analyst Decision
  • INVE Strong Buy
  • ENTX Strong Buy
  • Analyst Count
  • INVE 2
  • ENTX 1
  • Target Price
  • INVE $7.25
  • ENTX $10.00
  • AVG Volume (30 Days)
  • INVE 34.7K
  • ENTX 91.5K
  • Earning Date
  • INVE 03-11-2025
  • ENTX 03-07-2025
  • Dividend Yield
  • INVE N/A
  • ENTX N/A
  • EPS Growth
  • INVE N/A
  • ENTX N/A
  • EPS
  • INVE 3.10
  • ENTX N/A
  • Revenue
  • INVE $104,217,000.00
  • ENTX $99,000.00
  • Revenue This Year
  • INVE N/A
  • ENTX N/A
  • Revenue Next Year
  • INVE N/A
  • ENTX N/A
  • P/E Ratio
  • INVE $1.13
  • ENTX N/A
  • Revenue Growth
  • INVE 70.57
  • ENTX 607.14
  • 52 Week Low
  • INVE $2.95
  • ENTX $0.95
  • 52 Week High
  • INVE $9.24
  • ENTX $3.35
  • Technical
  • Relative Strength Index (RSI)
  • INVE 44.12
  • ENTX 54.06
  • Support Level
  • INVE $3.41
  • ENTX $2.21
  • Resistance Level
  • INVE $3.67
  • ENTX $2.62
  • Average True Range (ATR)
  • INVE 0.19
  • ENTX 0.21
  • MACD
  • INVE 0.01
  • ENTX -0.01
  • Stochastic Oscillator
  • INVE 27.91
  • ENTX 69.35

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: